Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07103616 · ClinicalTrials.gov registry record · Phase 4
Individual Cerebral Hemodynamic Oxygenation Relationships - ICHOR 4
A Phase 4 study, sponsored by Children's Hospital Los Angeles.
- Not yet
- Registry status
- Phase 4
- Development phase
- 130
- Enrollment target
NCT07103616 is a Phase 4 study that has not yet begun recruiting, run by Children's Hospital Los Angeles. The registered enrollment target is 130 participants.
The verdict
NCT07103616, a Phase 4 study, has not yet begun recruiting, sponsored by Children's Hospital Los Angeles.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 130 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to understand whether there are differences in the cerebral blood flow, and oxygen metabolism affected by two types of anesthesia: Propofol or Dexmedetomidine. Subjects who require clinical anesthesia for a clinical MRI and for whom the use of Propofol and Dexmedetomidine are in clinical equipoise will be offered to have the anesthesia they will receive during their MRI randomized. * Change in cerebral blood flow (ml blood/100g/min) * Change in cerebral metabolic rate of oxygen (ml O2/100g/min) Researchers will compare Propofol (Group A) to Dexmedetomidine (Group B) to see if compare the hemodynamic response to anesthesia. Participants will be randomized to receive one of two equally safe anesthetics (Propofol or Dexmedetomidine).
Interventions
- DRUG Randomization of Propofol or Dexmedetomidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2025-09-01 |
| Est. Completion | 2028-09-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07103616
The ClinicalTrials.gov registry entry for NCT07103616 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Los Angeles, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Randomization of Propofol or Dexmedetomidine is the first listed.
NCT07103616 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07103616 about?
NCT07103616 is a clinical study titled "Individual Cerebral Hemodynamic Oxygenation Relationships - ICHOR 4". The goal of this clinical trial is to understand whether there are differences in the cerebral blood flow, and oxygen metabolism affected by two types of anesthesia: Propofol or Dexmedetomidine. Subjects who require clinical anesthesia for a clinical MRI and for whom the use of Propofol and Dexmedet...
What is the current status of trial NCT07103616?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 130 participants. The study started on 2025-09-01. Estimated completion is 2028-09-01.
What interventions are being tested in trial NCT07103616?
The interventions under investigation include: Randomization of Propofol or Dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT07103616?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.